45
Views
0
CrossRef citations to date
0
Altmetric
Columns

Correspondence

Pages 1066-1074 | Published online: 06 Jul 2009

References

  • Tarrier N, Beckett R, Harwood S, Bishay N. Morbid jealousy: a review and cognitive-behavioral formulation. Br J Psychiatry 1990; 157: 319–326
  • Cobb JP, Marks IM. Morbid jealousy featuring as obsessive-compulsive neurosis: treatment by behavioral psychotherapy. Br J Psychiatry 1979; 134: 301–305
  • Gross MD. Treatment of morbid jealousy by fluoxetine. Am J Psychiatry 1991; 148: 683–684
  • Parker G, Barrett E. Morbid jealousy as a variant of obsessive-compulsive disorder. Aust N Z J Psychiatry 1997; 31: 133–138
  • Stein DJ, Hollander MD, Josephson SC. Serotonin reuptake blocker for treatment of obsessional jealousy. J Clin Psychiatry 1994; 55: 30–33
  • Marsálek M. Tardive drug induced extrapyramidal syndromes. Pharmacopsychiatry 2000; 33(Suppl 1)14–33
  • Caine ED, Polinsky RJ, Kartzinel R, Ebert MH. The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiatry 1979; 136: 317–320
  • Mukhopadhaya K, Krishnaiah R, Taye T et al. Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern. J Pharmacol 2008; [Epub ahead of print].
  • Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000; 42: 436–447
  • Sheppard DM, Bradshaw JL, Purcell R, Pantelis C. Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology?. Clin Psychol Rev 1999; 19: 531–552
  • Reid SD. Neuroleptic-induced tardive tourette treated with clonazepam: a case report and literature review. Clin Neuropharmacol 2004; 27: 101–104
  • Wong DF, Singer HS, Brandt J, et al. D2-like dopamine receptor density in Tourette syndrome measured by PET. J Nucl Med 1997; 38: 1243–1247
  • Fountoulakis KN, Siamouli M, Kantartzis S, Panagiotidis P, Iacovides A, St Kaprinis G. Acute dystonia with low-dosage aripiprazole in Tourette's disorder. Ann Pharmacother 2006; 40: 775–777
  • Seeman P. Atypical antipsychotics: Mechanism of action. Can J Psychiatry 2002; 47: 27–38
  • Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003; 5: 407–420
  • Fawcett J, Barkin RL. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord 1998; 51: 267–285
  • Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol 2005; 10: 37–45
  • Bhanji NH, Margolese HC, Saint-Laurent M, Chouinard G. Dysphoric mania induced by high dose mirtazapine: a case for “norepinephrine syndrome”. Int Clin Psychopharmacol 2002; 17: 319–322
  • Prost E. Mirtazapine-induced shopping spree. Can J Psychiatry 2004; 49: 495
  • Liu CC, Liang KY, Liao SC. Antidepressant-associated mania: soon after switch from fluoxetine to mirtazapine in an elderly woman with mixed depressive features. J Psychopharmacol 2008; [Epub ahead of print].
  • De Leon OA, Furmaga KM, Kaltsounis J. Mirtazapine induced mania in a case of poststroke depression. J Neuropsychiatry Clin Neurosci 1999; 11: 115–116
  • Soutullo CA, McElroy SL, Keck PE. Hypomania associated with mirtazapine augmentation of sertraline. J Clin Psychiatry 1998; 59: 320
  • Ng B. Mania associated with mirtazapine augmentation of fluoxetine. Depress Anxiety 2002; 15: 46–47
  • Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–435
  • Goldberg JF, Whiteside JE. The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry 2003; 63: 791–796
  • Howland RH. Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol 1996; 16: 425–427
  • Kraepelin E. Lehrbuch der Psychiatrie5th edn. Leipzig, Barth 1896
  • Bennett RM. Dual constraints on synapse formation and regression in schizophrenia: neuregulin, neuroligin, dysbindin, DISC1, MuSK and agrin. Aust N Z J Psychiatry 2008; 42: 662–677
  • Borgwardt SJ, Riecher-Rössler A, Dazzan P, et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 2007; 61: 1148–1156
  • Rasser P, Johnston P, Lagopoulos J, et al. Functional MRI BOLD response of Tower of London performance of first-episode schizophrenia patients using cortical pattern matching. Neuroimage 2005; 26: 941–951
  • Konopaske GT, Dorph-Petersen KA, Sweet RA, et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 2008; 63: 759–765
  • Sanders AR, Duan J, Levinson DF, et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008; 165: 497–506
  • Singareddy RK, Balon R. Sleep and suicide in psychiatric patients. Ann Clin Psychiatry 2001; 13: 93–101
  • Goldstein TR, Bridge JA, Brent DA. Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol 2008; 76: 84–91
  • Sabo E, Reynolds CF 3rd, Kupfer DJ, Berman SR. Sleep, depression, and suicide. Psychiatry Res 1991; 36: 265–277
  • Tononi G, Cirelly C. Sleep and synaptic homeostasis: a hypothesis. Brain Res Bull 2003; 62: 143–150
  • Sher L, Mann JJ. Neurobiology of suicide. Textbook of medical psychiatry, JC Soares, S Gershon. Marcel Dekker, New York 2003; 701–711
  • Hayes G, Gibler B. Clozapine-induced constipation. Am J Psychiatry 1995; 152: 298
  • Palmer SE, McLean RM, Ellis PM, Harrison-Woolrych M. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry 2008; 69: 759–768
  • Drew L, Herdson P. Clozapine and constipation: a serious issue. Aust N Z J Psychiatry 1997; 31: 149–150
  • Bickerstaff LK, Harris SC, Leggett RS, Cheah KC. Pain insensitivity in schizophrenic patients. A surgical dilemma. Arch Surg. 1988; 123: 49–51
  • MacMorran WS, Krahn LE. Adverse cutaneous reactions to psychotropic drugs. Psychosomatics 1997; 38: 413–422
  • Warnock JK, Knesevich JW. Adverse cutaneous reactions to antidepressants. Am J Psychiatry 1988; 145: 425–430
  • Hess E. Drug-related lupus. N Engl J Med 1988; 318: 1460–1462
  • Gladman DD, Urowitz MB. Drug-induced lupus. In: Schumacher HR, Klippel JH, Koopman WJ Primer on rheumatic diseases, 10th edn. Atlanta, GA: Arthritis Foundation; 1993:111–113.
  • Pramatov KD. Drug-induced lupus erythematosus. Clin Dermatol 1998; 16: 367–377
  • American Psychiatric Association. The practice of electroconvulsive therapy: recommendations for treatment, training and privileging. Washington, DC: APA Press, 1990.
  • Isenberg KE, Zorumski CF. Electroconvulsive therapy. In: Sadock BJ, Sadock VA. Kaplan and Sadock's comprehensive textbook of psychiatry, 7th edn, vol. 2. Philadelphia: Lippincott Williams and Wilkins, 2000:2503–2515.
  • Tiller JWG, Lyndon RW. High risk situations. Electroconvulsive therapy. an Australasian guide, JWG Tiller, RW Lyndon. Australian Postgraduate Medicine, Melbourne 2003; 21–28
  • Ruedrich SL, Chu CC, Moore SL. ECT for major depression in a patient with acute brain trauma. Am J Psychiatry 1983; 140: 928–929
  • Crow S, Meller W, Christenson G, Mackenzie T. Use of ECT after brain injury. Convuls Ther 1996; 12: 113–116

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.